|
US2293359A
(en)
*
|
1941-01-08 |
1942-08-18 |
Quisling Sverre |
Acetyl salicylic acid preparation
|
|
FR2224175B1
(cg-RX-API-DMAC7.html)
|
1973-04-04 |
1978-04-14 |
Isf Spa |
|
|
US4069819A
(en)
|
1973-04-13 |
1978-01-24 |
Societa Farmaceutici S.P.A. |
Inhalation device
|
|
BR8007911A
(pt)
|
1979-12-06 |
1981-06-16 |
Glaxo Group Ltd |
Inalador aperfeicoado
|
|
US4375468A
(en)
|
1981-07-13 |
1983-03-01 |
Verex Laboratories, Inc. |
Constant order release aspirin composition and method of treating arthritis
|
|
US4885287A
(en)
|
1988-08-09 |
1989-12-05 |
University Of Kentucky Research Foundation |
Novel method of administering aspirin and dosage forms containing same
|
|
US5511726A
(en)
|
1988-09-23 |
1996-04-30 |
Battelle Memorial Institute |
Nebulizer device
|
|
IT1228459B
(it)
|
1989-02-23 |
1991-06-19 |
Phidea S R L |
Inalatore con svuotamento regolare e completo della capsula.
|
|
ATE179605T1
(de)
*
|
1991-02-09 |
1999-05-15 |
B S D Bio Science Dev Snc Di O |
Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation
|
|
EP0499142A3
(en)
|
1991-02-09 |
1993-05-05 |
Hoechst Aktiengesellschaft |
Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
|
|
US5256538A
(en)
*
|
1991-03-08 |
1993-10-26 |
Board Of Regents, The University Of Texas System |
Detection of early platelet activation and prediagnosis of thrombotic events
|
|
US5993805A
(en)
|
1991-04-10 |
1999-11-30 |
Quadrant Healthcare (Uk) Limited |
Spray-dried microparticles and their use as therapeutic vehicles
|
|
US5327883A
(en)
|
1991-05-20 |
1994-07-12 |
Dura Pharmaceuticals, Inc. |
Apparatus for aerosolizing powdered medicine and process and using
|
|
GB2265845B
(en)
|
1991-11-12 |
1996-05-01 |
Medix Ltd |
A nebuliser and nebuliser control system
|
|
US5639441A
(en)
|
1992-03-06 |
1997-06-17 |
Board Of Regents Of University Of Colorado |
Methods for fine particle formation
|
|
US6098620A
(en)
|
1993-01-29 |
2000-08-08 |
Aradigm Corporation |
Device for aerosolizing narcotics
|
|
US5724957A
(en)
|
1993-01-29 |
1998-03-10 |
Aradigm Corporation |
Intrapulmonary delivery of narcotics
|
|
US20070116761A1
(en)
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
|
GB9322014D0
(en)
*
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
|
PT101450B
(pt)
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
MX9707862A
(es)
|
1995-04-14 |
1997-11-29 |
Glaxo Wellcome Inc |
Inhalador de dosis medida para el propionato de fluticasona.
|
|
AU706195B2
(en)
|
1995-04-14 |
1999-06-10 |
Inhale Therapeutic Systems |
Powdered pharmaceutical formulations having improved dispersibility
|
|
US6209538B1
(en)
|
1995-08-02 |
2001-04-03 |
Robert A. Casper |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
|
US5875776A
(en)
|
1996-04-09 |
1999-03-02 |
Vivorx Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
|
US6503480B1
(en)
|
1997-05-23 |
2003-01-07 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US6131570A
(en)
|
1998-06-30 |
2000-10-17 |
Aradigm Corporation |
Temperature controlling device for aerosol drug delivery
|
|
US20010031244A1
(en)
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
|
ATE248583T1
(de)
|
1997-09-29 |
2003-09-15 |
Nektar Therapeutics |
In dosierinhalatoren verwendbare, stabilisierte zubereitungen
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
GB9807232D0
(en)
|
1998-04-03 |
1998-06-03 |
Univ Cardiff |
Aerosol composition
|
|
US6284282B1
(en)
|
1998-04-29 |
2001-09-04 |
Genentech, Inc. |
Method of spray freeze drying proteins for pharmaceutical administration
|
|
WO2000000215A1
(en)
|
1998-06-29 |
2000-01-06 |
Inhale Therapeutic Systems, Inc. |
Particulate delivery systems and methods of use
|
|
GB9814172D0
(en)
|
1998-06-30 |
1998-08-26 |
Andaris Ltd |
Formulation for inhalation
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
KR20010111564A
(ko)
|
1998-11-12 |
2001-12-19 |
프랭크 쥐. 필키윅즈 |
흡입 시스템
|
|
JP3739955B2
(ja)
|
1999-01-11 |
2006-01-25 |
株式会社日立製作所 |
吸入式投薬器
|
|
US6630169B1
(en)
|
1999-03-31 |
2003-10-07 |
Nektar Therapeutics |
Particulate delivery systems and methods of use
|
|
US7919119B2
(en)
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6858199B1
(en)
|
2000-06-09 |
2005-02-22 |
Advanced Inhalation Research, Inc. |
High efficient delivery of a large therapeutic mass aerosol
|
|
AU1068401A
(en)
|
1999-10-12 |
2001-04-23 |
Shl Medical Ab |
Inhaler
|
|
EP1093814A1
(en)
|
1999-10-22 |
2001-04-25 |
Boehringer Ingelheim Pharma KG |
Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
|
|
US20030176421A1
(en)
|
1999-12-30 |
2003-09-18 |
Watson John W. |
Prokinetic agents for treating gastric hypomotility and related disorders
|
|
PL204106B1
(pl)
|
2000-02-28 |
2009-12-31 |
Pharmakodex Ltd |
Zestaw do dostarczania środka terapeutycznego
|
|
US6998137B2
(en)
|
2000-04-07 |
2006-02-14 |
Macromed, Inc. |
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
|
|
GB0009469D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formalities for use in inhaler devices
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
GB0010709D0
(en)
|
2000-05-03 |
2000-06-28 |
Vectura Ltd |
Powders for use a in dry powder inhaler
|
|
EP1177805A1
(en)
|
2000-07-31 |
2002-02-06 |
Maryland Financial Inc. |
Powder inhaler
|
|
FR2812545B1
(fr)
|
2000-08-03 |
2003-03-28 |
Air Liquide Sante Int |
Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
|
|
MXPA03001092A
(es)
|
2000-08-07 |
2003-09-25 |
Nektar Therapeutics Al Corp |
Polvos de proteina de haz de 4 helices secados por rocio, inhalables, que tienen agregacion minimizada.
|
|
US20020025917A1
(en)
|
2000-08-28 |
2002-02-28 |
Edward Pappalardo |
Compartmentalized device to enable a process of liquefying and administering aspirin as a first aid to heart attack victims
|
|
US6613308B2
(en)
*
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
FI20002215A0
(fi)
|
2000-10-06 |
2000-10-06 |
Orion Yhtymae Oyj |
Yhdistelmäpartikkelit
|
|
WO2002051389A2
(en)
|
2000-12-22 |
2002-07-04 |
Aspen Aerogels, Inc. |
Aerogel powder comprising therapeutic agents
|
|
CZ297570B6
(cs)
|
2000-12-25 |
2007-02-07 |
Sankyo Company, Limited |
Farmaceutický prípravek obsahující 2-acetoxypyridinový derivát a aspirin, které spolu pusobí v synergickém úcinku, kit jej obsahující a pouzití
|
|
EP1238680B1
(en)
|
2001-03-05 |
2003-12-10 |
Ivo Pera |
Inhaling device for dispersing powdered medicaments contained in a capsule through the respiratory tract
|
|
US20060293217A1
(en)
|
2001-03-19 |
2006-12-28 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained release
|
|
US6766799B2
(en)
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
|
US6848197B2
(en)
*
|
2001-04-18 |
2005-02-01 |
Advanced Inhalation Research, Inc. |
Control of process humidity to produce large, porous particles
|
|
US6455028B1
(en)
|
2001-04-23 |
2002-09-24 |
Pharmascience |
Ipratropium formulation for pulmonary inhalation
|
|
US20040049022A1
(en)
|
2001-04-24 |
2004-03-11 |
Nyce Jonathan W. |
Composition & methods for treatment and screening
|
|
CA2446904A1
(en)
|
2001-05-24 |
2003-04-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of drug esters through an inhalation route
|
|
CA2465675C
(en)
|
2001-11-20 |
2008-06-10 |
Advanced Inhalation Research, Inc. |
Improved particulate compositions for pulmonary delivery
|
|
GB0129270D0
(en)
|
2001-12-06 |
2002-01-23 |
Pfizer Ltd |
Pharmaceutical combination
|
|
GB0129397D0
(en)
|
2001-12-07 |
2002-01-30 |
Pfizer Ltd |
Pharmaceutical combination
|
|
ITMI20020078A1
(it)
|
2002-01-16 |
2003-07-16 |
Fabrizio Niccolai |
Dispositivo utilizzabile nel tratamento di affezzioni delle vie respiratorie
|
|
WO2003072080A1
(en)
|
2002-02-22 |
2003-09-04 |
Advanced Inhalation Research, Inc. |
Inhalable formulations for sustained release
|
|
SE524990C2
(sv)
|
2002-04-12 |
2004-11-09 |
Microdrug Ag |
Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
|
|
US7405207B2
(en)
|
2002-06-17 |
2008-07-29 |
Epigenesis Pharmaceuticals, Inc. |
Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
|
|
AU2003276131A1
(en)
|
2002-06-18 |
2003-12-31 |
Epigenesis Pharmaceuticals, Inc. |
A dry powder oligonucleotide formulation, preparation and its uses
|
|
CN1694689A
(zh)
|
2002-09-30 |
2005-11-09 |
阿库斯菲尔公司 |
供吸入的缓释多孔微粒
|
|
GB0226105D0
(en)
|
2002-11-08 |
2002-12-18 |
St Georges S Entpr Ltd |
Pain relief agents
|
|
US7516741B2
(en)
|
2002-12-06 |
2009-04-14 |
Novartis Ag |
Aerosolization apparatus with feedback mechanism
|
|
US7284553B2
(en)
|
2002-12-12 |
2007-10-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient
|
|
SE0203687D0
(sv)
|
2002-12-13 |
2002-12-13 |
Ian Harwigsson Med Adagit Fa |
Pharmaceutical Porous Particles
|
|
US20040206350A1
(en)
|
2002-12-19 |
2004-10-21 |
Nektar Therapeutics |
Aerosolization apparatus with non-circular aerosolization chamber
|
|
US7669596B2
(en)
|
2002-12-31 |
2010-03-02 |
Novartis Pharma Ag |
Aerosolization apparatus with rotating capsule
|
|
US7878193B2
(en)
|
2003-01-14 |
2011-02-01 |
Boehringer Ingelheim International Gmbh |
Capsule for taking an active substance which can be inhaled
|
|
AU2004229446B2
(en)
|
2003-04-09 |
2010-02-25 |
Bgp Products Operations Gmbh |
Aerosolization apparatus with air inlet shield
|
|
CA2520265C
(en)
|
2003-04-09 |
2015-02-17 |
Bgp Products Operations Gmbh |
Aerosolization apparatus with capsule puncture alignment guide
|
|
AU2004229567A1
(en)
|
2003-04-09 |
2004-10-28 |
Wyeth |
Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof
|
|
GB0312419D0
(en)
|
2003-05-30 |
2003-07-02 |
Boots Healthcare Int Ltd |
Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
|
|
AU2004249166B2
(en)
|
2003-06-13 |
2008-10-09 |
Alkermes, Inc. |
Low dose pharmaceutical powders for inhalation
|
|
SE527069C2
(sv)
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
|
US8075919B2
(en)
|
2003-07-18 |
2011-12-13 |
Baxter International Inc. |
Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
|
|
JP2007502815A
(ja)
|
2003-08-20 |
2007-02-15 |
イーライ リリー アンド カンパニー |
Ppar調節因子
|
|
CN1838958A
(zh)
|
2003-08-22 |
2006-09-27 |
贝林格尔·英格海姆药物公司 |
治疗慢性阻塞性肺病和肺动脉高血压的方法
|
|
US20050249697A1
(en)
|
2003-09-24 |
2005-11-10 |
Uhrich Kathryn E |
Compositions and methods for the inhibition of bone growth and resorption
|
|
GB2407040B
(en)
|
2003-10-15 |
2007-09-19 |
Sheikh Arshad Saeed |
Anti-platelet aggregation compositions
|
|
WO2005040163A1
(en)
|
2003-10-28 |
2005-05-06 |
Dr. Reddy's Laboratories Ltd |
Heterocyclic compounds that block the effects of advanced glycation end products (age)
|
|
WO2005041886A2
(en)
|
2003-10-31 |
2005-05-12 |
Metaphore Pharmaceuticals, Inc. |
Methods for generating or increasing revenues related to pain inhibitor commerce
|
|
US20070232575A1
(en)
|
2004-02-05 |
2007-10-04 |
Baulieu Etienne E |
Treatment of Pulmonary Artery Hypertension with Dhea, Dheas, Dhea Analogs, or Dhea Derivatives
|
|
AU2005216969A1
(en)
|
2004-02-23 |
2005-09-09 |
Prolexys Pharmaceuticals Inc. |
Non-peptidyl agents with pHSP20-like activity, and uses thereof
|
|
BRPI0510119A
(pt)
|
2004-04-23 |
2007-09-25 |
Cydex Inc |
formulação para dpi contendo sulfoaquil éter de ciclodextrina
|
|
AU2005238291A1
(en)
|
2004-05-04 |
2005-11-10 |
Pfizer Inc. |
Substituted methyl aryl or heteroaryl amide compounds
|
|
US7189750B2
(en)
|
2004-05-05 |
2007-03-13 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof
|
|
US7968575B2
(en)
|
2004-05-05 |
2011-06-28 |
Renopharm Ltd. |
Nitric oxide donors and uses thereof
|
|
US7244709B2
(en)
|
2004-05-10 |
2007-07-17 |
Nastech Pharamecutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of parathyroid hormone
|
|
US7556035B2
(en)
|
2004-05-28 |
2009-07-07 |
Quadrant Technologies Limited |
Unit dose dry powder inhaler
|
|
CA2570048A1
(en)
|
2004-07-07 |
2006-01-12 |
Medicure International Inc. |
Combination therapies employing platelet aggregation drugs
|
|
WO2006017354A1
(en)
|
2004-07-13 |
2006-02-16 |
Pharmacofore, Inc. |
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing disease or pain
|
|
WO2006017505A2
(en)
|
2004-08-04 |
2006-02-16 |
Schering Corporation |
Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
|
|
ATE539757T1
(de)
|
2004-11-02 |
2012-01-15 |
Univ Leland Stanford Junior |
Verfahren zur hemmung von nkt-zellen
|
|
GB0425758D0
(en)
*
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
|
ITMI20050417A1
(it)
*
|
2005-03-15 |
2006-09-16 |
Medestea Res & Production S R L |
Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica
|
|
EP1888257A1
(en)
|
2005-05-05 |
2008-02-20 |
Pulmatrix, Inc. |
Ultrasonic aerosol generator
|
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
|
US20090220435A1
(en)
|
2005-07-27 |
2009-09-03 |
Nastech Pharmaceutical Company Inc. |
Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents
|
|
ITMI20051999A1
(it)
|
2005-10-21 |
2007-04-22 |
Eratech S R L |
Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
|
|
US20070178166A1
(en)
|
2005-12-15 |
2007-08-02 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
MX2008007697A
(es)
|
2005-12-16 |
2008-09-26 |
Univ Kansas |
Nanocumulos para la distribucion de farmacos.
|
|
WO2007072503A2
(en)
|
2005-12-21 |
2007-06-28 |
Panacea Biotec Ltd. |
Combinations for managing inflammation and associated disorders
|
|
US7201929B1
(en)
|
2005-12-30 |
2007-04-10 |
Alan James Group, Llc. |
Aspirin formulation for cardiovascular health
|
|
WO2007114881A1
(en)
|
2006-01-24 |
2007-10-11 |
Nexbio, Inc. |
Technology for preparation of macromolecular microspheres
|
|
GB0605723D0
(en)
|
2006-03-23 |
2006-05-03 |
3M Innovative Properties Co |
Powder filling processes
|
|
US7806117B2
(en)
|
2006-06-07 |
2010-10-05 |
Shin Nippon Biomedical Laboratories, Ltd. |
Peroral powder delivery device
|
|
US8201555B2
(en)
|
2006-06-27 |
2012-06-19 |
Brintech International Limited |
Inhaler
|
|
PT2068889T
(pt)
|
2006-08-10 |
2020-01-30 |
Roy C Levitt |
Anakinra para uso no tratamento da síndrome da bronquiolite obliterante
|
|
GB0617171D0
(en)
|
2006-08-31 |
2006-10-11 |
Generics Uk Ltd |
Novel compositions and methods
|
|
US20080063722A1
(en)
*
|
2006-09-08 |
2008-03-13 |
Advanced Inhalation Research, Inc. |
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
|
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
US7767206B2
(en)
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
|
GB0621957D0
(en)
|
2006-11-03 |
2006-12-13 |
Vectura Group Plc |
Inhaler devices and bespoke pharmaceutical compositions
|
|
NL1033047C2
(nl)
|
2006-12-13 |
2008-06-16 |
Pharmachemie Bv |
Capsule, gevuld met een medicijn, in het bijzonder een inhaleerbaar medicijn.
|
|
GB0625303D0
(en)
|
2006-12-19 |
2007-01-24 |
Jagotec Ag |
Improvements in and relating to metered dose inhalers
|
|
GB0700839D0
(en)
|
2007-01-17 |
2007-02-21 |
Braithwaite Philip |
Device
|
|
EP1964564A1
(en)
|
2007-04-19 |
2008-09-03 |
LAB International SRL |
Breakthrough Pain Management
|
|
US8530463B2
(en)
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
|
EP2170958A1
(en)
|
2007-06-13 |
2010-04-07 |
Amgen Inc. |
Il-17 heteromeric receptor complex
|
|
CA2693771A1
(en)
|
2007-07-13 |
2009-01-22 |
Abbott Biotechnology Ltd. |
Methods and compositions for pulmonary administration of a tnf.alpha. inhibitor
|
|
RU2010102865A
(ru)
|
2007-07-24 |
2011-08-27 |
НексБио, Инк. (US) |
Технология изготовления микрочастиц
|
|
US9358242B2
(en)
|
2007-08-30 |
2016-06-07 |
Prelief Inc. |
Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
|
|
CN101888867B
(zh)
|
2007-12-05 |
2013-05-15 |
诺瓦提斯公司 |
用于可雾化的药物制剂的容器
|
|
EP2227085A4
(en)
|
2007-12-06 |
2013-10-09 |
Berg Pharma Llc |
INGREDIBLE COMPOSITIONS WITH INCREASED BIOLOGICAL AVAILABILITY
|
|
US20090196930A1
(en)
|
2007-12-27 |
2009-08-06 |
Aires Pharmaceuticals, Inc. |
Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
|
|
JP2011510017A
(ja)
|
2008-01-15 |
2011-03-31 |
ユニベルシテ・ドウ・ストラスブール |
治療薬として有用なレゾルシン酸ラクトンの合成
|
|
JP2011514335A
(ja)
|
2008-02-21 |
2011-05-06 |
アムジェン インコーポレイテッド |
Il−17ra−il−17rbアンタゴニストおよび該アンタゴニストの使用
|
|
GB0803369D0
(en)
|
2008-02-25 |
2008-04-02 |
Helperby Therapeutics Ltd |
Biological materials and uses thereof
|
|
MX2010010877A
(es)
|
2008-04-04 |
2010-10-26 |
Irm Llc |
Compuestos y composiciones como inhibidores de itpkb.
|
|
CN102065694A
(zh)
|
2008-04-15 |
2011-05-18 |
萨可德公司 |
用于局部治疗免疫相关疾病的雾化的lfa-1拮抗剂
|
|
CA2722418C
(en)
|
2008-05-13 |
2013-09-17 |
Irm Llc |
Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
|
|
US20110112134A1
(en)
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
|
MY155524A
(en)
|
2008-06-13 |
2015-10-30 |
Mannkind Corp |
A dry powder inhaler and system for drug delivery
|
|
EP2318049A1
(en)
|
2008-07-15 |
2011-05-11 |
Schering Corporation |
Intranasal compositions comprising a decongestant and a corticosteroid
|
|
WO2010007447A1
(en)
|
2008-07-18 |
2010-01-21 |
Prosonix Limited |
Process for improving crystallinity
|
|
WO2010011329A2
(en)
|
2008-07-23 |
2010-01-28 |
Map Pharmaceuticals, Inc. |
The delivery of powdered drug via inhalation
|
|
US8236786B2
(en)
|
2008-08-07 |
2012-08-07 |
Pulmagen Therapeutics (Inflammation) Limited |
Respiratory disease treatment
|
|
MX2011002688A
(es)
|
2008-09-12 |
2011-04-12 |
Critical Pharmaceuticals Ltd |
Mejoramientos en la absorcion de agentes terapeuticos a traves de las membranas mucosas o la piel.
|
|
PE20120647A1
(es)
|
2009-03-13 |
2012-05-31 |
Nucitec Sa De Cv |
Composiciones y metodos para el tratamiento y prevencion de la enfermedad cardiovascular
|
|
JP5671001B2
(ja)
*
|
2009-03-26 |
2015-02-18 |
パルマトリックス,インコーポレイテッド |
肺疾患を治療するための乾燥粉末製剤および方法
|
|
US20120046251A1
(en)
|
2009-04-06 |
2012-02-23 |
The Regents Of The University Of California |
Inhibitors of soluble epoxide hydrolase to inhibit or prevent niacin-induced flushing
|
|
CA2759026C
(en)
|
2009-04-20 |
2019-01-15 |
Auspex Pharmaceuticals, Inc. |
Piperidine inhibitors of janus kinase 3
|
|
GB0908129D0
(en)
|
2009-05-12 |
2009-06-24 |
Innovata Ltd |
Composition
|
|
US9101539B2
(en)
|
2009-05-15 |
2015-08-11 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal pharmaceutical compositions with improved pharmacokinetics
|
|
WO2010135340A2
(en)
|
2009-05-18 |
2010-11-25 |
3M Innovative Properties Company |
Dry powder inhalers
|
|
ES2662769T3
(es)
|
2009-05-18 |
2018-04-09 |
Adamis Pharmaceuticals Corporation |
Contadores de dosis de inhalador de polvo seco
|
|
JP2012528844A
(ja)
|
2009-06-01 |
2012-11-15 |
バイオコピア リミテッド |
好中球によって引き起こされる疾患の治療におけるアンレキサノクスの使用
|
|
GB201111485D0
(en)
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
GB0914231D0
(en)
*
|
2009-08-14 |
2009-09-30 |
Breath Ltd |
Dry powder inhaler formulations
|
|
GB0917054D0
(en)
|
2009-09-29 |
2009-11-11 |
Cytoguide As |
Agents, uses and methods
|
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
|
GB0918431D0
(en)
|
2009-10-21 |
2009-12-09 |
Prosonix Ltd |
Process for improving crystallinity
|
|
GB0921481D0
(en)
|
2009-12-08 |
2010-01-20 |
Vectura Ltd |
Process and product
|
|
MX2012011629A
(es)
|
2010-04-07 |
2013-03-05 |
Abbvie Inc |
Proteinas de union a tnf-alfa.
|
|
WO2012030664A1
(en)
|
2010-08-30 |
2012-03-08 |
Pulmatrix, Inc. |
Dry powder formulations and methods for treating pulmonary diseases
|
|
WO2012037665A1
(en)
|
2010-09-24 |
2012-03-29 |
Oral Delivery Technology Ltd. |
Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
|
|
WO2012061902A1
(en)
|
2010-11-12 |
2012-05-18 |
Monash University |
Micronised spray-dried particles comprising polymyxin
|
|
WO2012078804A1
(en)
|
2010-12-07 |
2012-06-14 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
|
CN102058886A
(zh)
|
2010-12-20 |
2011-05-18 |
云南白药集团无锡药业有限公司 |
医用粉雾剂及其应用
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
GB201102237D0
(en)
|
2011-02-09 |
2011-03-23 |
Kuecept Ltd |
Particle formulation
|
|
CN108014340A
(zh)
|
2011-04-12 |
2018-05-11 |
莫伊莱麦屈克斯公司 |
用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病的组合物和方法
|
|
US8580853B2
(en)
*
|
2011-06-13 |
2013-11-12 |
Howard PHYKITT |
Analgesic composition and method of making the same
|
|
US20140239525A1
(en)
|
2011-06-17 |
2014-08-28 |
Board Of Regents, University Of Texas System |
Inhalable pharmaceutical compositions
|
|
US20140234330A1
(en)
|
2011-07-22 |
2014-08-21 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
|
EP2753323A1
(en)
|
2011-09-06 |
2014-07-16 |
Verona Pharma PLC |
Treating cough and tussive attacks
|
|
ES2644922T3
(es)
|
2011-12-16 |
2017-12-01 |
Indosys Limited |
Cartucho de dosis unitaria de medicamento y dispositivo de suministro
|
|
HK1205156A1
(en)
|
2012-01-31 |
2015-12-11 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
CN107875127A
(zh)
|
2012-02-28 |
2018-04-06 |
艾塞尤提卡控股公司 |
可吸入药物组合物
|
|
US20150136130A1
(en)
|
2012-02-29 |
2015-05-21 |
Pulmatrix, Inc. |
Inhalable dry powders
|
|
AU2013240139B2
(en)
|
2012-03-26 |
2017-02-23 |
Arroyo Biosciences L.L.C. |
Novel sphingosine 1-phosphate receptor antagonists
|
|
GB201205632D0
(en)
|
2012-03-30 |
2012-05-16 |
Vectura Ltd |
Method and apparatus
|
|
CN111700878A
(zh)
|
2012-05-03 |
2020-09-25 |
卡拉制药公司 |
显示提高的粘膜转移的药物纳米粒子
|
|
US10105500B2
(en)
*
|
2012-05-09 |
2018-10-23 |
Virginia Commonwealth University |
Dry powder inhaler (DPI) designs for producing aerosols with high fine particle fractions
|
|
SG11201407676VA
(en)
|
2012-05-21 |
2015-03-30 |
Agency Science Tech & Res |
A dry powder formulation
|
|
EP2863892B1
(en)
|
2012-06-20 |
2017-11-08 |
University Of Waterloo |
Mucoadhesive nanoparticle delivery system
|
|
WO2014048065A1
(en)
|
2012-09-28 |
2014-04-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
|
EP2903622A1
(en)
|
2012-10-03 |
2015-08-12 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
|
|
US20150284381A1
(en)
|
2012-11-07 |
2015-10-08 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
|
CN110464724A
(zh)
|
2013-01-28 |
2019-11-19 |
理森制药股份公司 |
通过吸入罗氟司特n-氧化物治疗自身免疫、呼吸和/或炎性病症的方法
|
|
TWI643853B
(zh)
|
2013-02-27 |
2018-12-11 |
阿爾米雷爾有限公司 |
同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
|
|
GB201305813D0
(en)
|
2013-03-28 |
2013-05-15 |
Vectura Ltd |
Compositions and methods
|
|
CN105473133A
(zh)
|
2013-04-30 |
2016-04-06 |
欧缇托匹克公司 |
干粉制剂及使用方法
|
|
EP2999337A4
(en)
|
2013-05-23 |
2017-03-15 |
Aztherapies, Inc |
Methods for delivering cromolyn
|
|
TWI641373B
(zh)
|
2013-07-25 |
2018-11-21 |
阿爾米雷爾有限公司 |
具有蕈毒鹼受體拮抗劑和β2腎上腺素受體促效劑二者之活性的2-胺基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽
|
|
ES2959419T3
(es)
|
2013-10-11 |
2024-02-26 |
Pulmokine Inc |
Formulaciones secas por aspersión
|
|
CA3177696A1
(en)
|
2014-02-20 |
2015-08-27 |
Allergan, Inc. |
Complement component c5 antibodies
|
|
EP3107548B8
(en)
|
2014-02-20 |
2022-07-20 |
Otitopic Inc. |
Dry powder formulations for inhalation
|
|
AU2015223056B2
(en)
|
2014-02-27 |
2020-10-01 |
Allergan, Inc. |
Complement Factor Bb antibodies
|
|
US10344037B2
(en)
|
2014-03-26 |
2019-07-09 |
Canget BioTek Pharma LLC |
Use of the FL-one hundred eighteen core chemical structure platform to generate FL-one hundred eighteen derivatives for treatment of human disease
|
|
WO2015153838A1
(en)
|
2014-04-02 |
2015-10-08 |
Rogne Bioscience Inc. |
Methods and compositions for treating inflammatory disorders
|
|
EP3129013A1
(en)
|
2014-04-10 |
2017-02-15 |
Crowley, Patrick |
Delivery of non-steroidal antiinflammatory agents to the brain via the nasal tract to treat neurological disorders
|
|
WO2016176552A1
(en)
*
|
2015-04-30 |
2016-11-03 |
Otitopic Inc. |
Dry power formulations for inhalation
|
|
EP3463378A4
(en)
*
|
2016-06-03 |
2020-01-08 |
Otitopic Inc. |
DRY POWDER FORMULAS FOR INHALATION
|
|
US10786456B2
(en)
*
|
2017-09-22 |
2020-09-29 |
Otitopic Inc. |
Inhaled aspirin and magnesium to treat inflammation
|
|
CA3076353A1
(en)
*
|
2017-09-22 |
2019-03-28 |
Otitopic Inc. |
Dry powder compositions with magnesium stearate
|